Emergent BioSolutions, Inc. (EBS)
5.17
+0.09
(+1.77%)
USD |
NYSE |
Aug 24, 16:00
5.17
0.00 (0.00%)
After-Hours: 20:00
Emergent BioSolutions Shareholders Equity (Quarterly) : 341.40M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 341.40M |
| March 31, 2026 | 523.10M |
| December 31, 2025 | 522.60M |
| September 30, 2025 | 582.50M |
| June 30, 2025 | 536.20M |
| March 31, 2025 | 552.70M |
| December 31, 2024 | 482.80M |
| September 30, 2024 | 508.40M |
| June 30, 2024 | 386.30M |
| March 31, 2024 | 663.90M |
| December 31, 2023 | 649.30M |
| September 30, 2023 | 697.20M |
| June 30, 2023 | 956.30M |
| March 31, 2023 | 1.203B |
| December 31, 2022 | 1.388B |
| September 30, 2022 | 1.449B |
| June 30, 2022 | 1.513B |
| March 31, 2022 | 1.575B |
| December 31, 2021 | 1.612B |
| September 30, 2021 | 1.523B |
| June 30, 2021 | 1.544B |
| March 31, 2021 | 1.523B |
| December 31, 2020 | 1.447B |
| September 30, 2020 | 1.252B |
| June 30, 2020 | 1.199B |
| Date | Value |
|---|---|
| March 31, 2020 | 1.075B |
| December 31, 2019 | 1.088B |
| September 30, 2019 | 1.035B |
| June 30, 2019 | 988.90M |
| March 31, 2019 | 987.50M |
| December 31, 2018 | 1.011B |
| September 30, 2018 | 966.65M |
| June 30, 2018 | 938.35M |
| March 31, 2018 | 881.28M |
| December 31, 2017 | 912.34M |
| September 30, 2017 | 663.71M |
| June 30, 2017 | 620.60M |
| March 31, 2017 | 610.42M |
| December 31, 2016 | 596.20M |
| September 30, 2016 | 547.62M |
| June 30, 2016 | 672.67M |
| March 31, 2016 | 666.98M |
| December 31, 2015 | 660.02M |
| September 30, 2015 | 605.31M |
| June 30, 2015 | 562.25M |
| March 31, 2015 | 537.88M |
| December 31, 2014 | 553.20M |
| September 30, 2014 | 513.14M |
| June 30, 2014 | 487.77M |
| March 31, 2014 | 477.50M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Exelixis, Inc. | 1.844B |
| Capricor Therapeutics, Inc. | 246.22M |
| ADMA Biologics, Inc. | 408.21M |
| Akebia Therapeutics, Inc. | 25.02M |
| Arcutis Biotherapeutics, Inc. | 220.58M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.117B |
| Total Liabilities (Quarterly) | 775.40M |
| Debt to Equity Ratio | 1.723 |
| Current Ratio | 5.424 |
| Net Debt Paydown Yield | 3.93% |